Chronic kidney disease duration and suicide risk among maintenance hemodialysis patients in China - Wang X, Hao X, Ma M, Jiang W, Li B, Xu Y, Sun P.
BACKGROUND: Our aim was to investigate the relationship between chronic kidney disease (CKD) duration and suicide risk among maintenance hemodialysis patients in China. METHODS: Patients with end-stage renal disease (ESRD) who received MHD were enr... (Source: SafetyLit)
Source: SafetyLit - March 22, 2024 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Hemodialysis History Does Not Impact Peritoneal Dialysis Dropout
THURSDAY, March 21, 2024 -- Peritoneal dialysis (PD) dropout seems not to be influenced by a history of hemodialysis (HD), according to a review published online March 5 in BMC Nephrology.
Xingge Sun, from Queen ' s University Belfast in the United... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2024 Category: Pharmaceuticals Source Type: news
Associations of vitamin D receptor activators and calcimimetics with falls and effect modifications by physical activity: a prospective cohort study on the Japan Dialysis Outcomes and Practice Patterns Study - Murashima M, Yamamoto R, Kanda E, Kurita N, Noma H, Hamano T, Fukagawa M.
This study aimed to examine the associations of vitamin D receptor activators (VDRA) and calcimimetics use with falls. METHODS: This is a prospective cohort study on hemodialysis patients in the Japan Dialysis Outcomes and Practice Pa... (Source: SafetyLit)
Source: SafetyLit - March 15, 2024 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
CEUS shines in diagnostic, interventional settings
Dynamic contrast-enhanced ultrasound (CEUS) is a useful tool for interventions, according to a March 3 presentation given at ECR 2024. In his talk, Dean Huang, MD, from King’s College London in England outlined novel applications for CEUS in vascular and nonvascular imaging, as well as therapeutic and potential future applications. “Ultrasound contrast agent use can be ubiquitous in interventional practice and can solve many logistical or clinical diagnostic problems,” he said. “And we can achieve all of this without the use of radiation and nephrotoxicity.” Dean Huang, MD, from King's College London highligh...
Source: AuntMinnie.com Headlines - March 6, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Source Type: news
Prediction the prognosis of the poisoned patients undergoing hemodialysis using machine learning algorithms - Rahimi M, Afrash MR, Shadnia S, Mostafazadeh B, Evini PET, Bardsiri MS, Ramezani M.
BACKGROUND: Hemodialysis is a life-saving treatment used to eliminate toxins and metabolites from the body during poisoning. Despite its effectiveness, there needs to be more research on this method precisely, with most studies focusing on specific poisoni... (Source: SafetyLit)
Source: SafetyLit - February 9, 2024 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
FDA Slams Fresenius Over Its Response to PCBs in Dialysis Machines
(MedPage Today) -- Dialysis giant Fresenius is at odds with the FDA following a protracted effort to address concerns about its hemodialysis machines.
In a warning letter posted in December, the FDA listed violations related to Fresenius' slow... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - January 23, 2024 Category: American Health Source Type: news
Top Insomnia Treatments Offer Little Relief for Dialysis Patients
(MedPage Today) -- Two common treatments for insomnia flopped for patients undergoing hemodialysis, according to the SLEEP-HD trial.
After 6 weeks of treatment, people who underwent cognitive behavioral therapy for insomnia (CBT-I) or took trazodone... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - January 16, 2024 Category: Primary Care Source Type: news
Cognitive Therapy or Trazodone Not Effective for Insomnia in Hemodialysis
TUESDAY, Jan. 16, 2024 -- For patients undergoing hemodialysis with chronic insomnia, the effectiveness of cognitive behavioral therapy for insomnia (CBT-I) or trazodone does not differ from placebo, according to a study published online Jan. 16 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 16, 2024 Category: Pharmaceuticals Source Type: news
Severe caffeine poisoning treated with intermittent hemodialysis under circulatory support: a case report - Mitsui D, Kamijo Y, Yoshino T, Hanazawa T, Yoshizawa T, Iwase F.
In this report, we describe a case of severe caffeine poisoning with extraordinarily high blood caffeine levels. Despite developing refractory ventricular fibrillation, the patient was successfull... (Source: SafetyLit)
Source: SafetyLit - December 25, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
FDA Approves DefenCath (taurolidine and heparin) to Reduce the Incidence of Catheter-Related Bloodstream Infections in Adult Hemodialysis Patients
Berkeley Heights, NJ– November 15, 2023– CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 15, 2023 Category: Drugs & Pharmacology Source Type: news
CorMedix Inc. Announces FDA Approval of DefenCath ® to Reduce the Incidence of Catheter-Related Bloodstream Infections in Adult Hemodialysis Patients
First and only FDA-approved antimicrobial catheter lock solution in the U.S. – Company expects DefenCath to be available in Q1 2024 in the inpatient setting BERKELEY HEIGHTS, N.J., Nov. 15, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. CRMD, a biopharmaceutical company focused on developing and…#fda #defencath #berkeleyheights #cormedixinc #crbsis #josephtodisco #cormedix #phase3lock #edwardvhickey #uscongress (Source: Reuters: Health)
Source: Reuters: Health - November 15, 2023 Category: Consumer Health News Source Type: news
Low muscle strength and physical function contribute to falls in hemodialysis patients, but not muscle mass - Shirai N, Yamamoto S, Osawa Y, Tsubaki A, Morishita S, Sugahara T, Narita I.
INTRODUCTION: Patients on hemodialysis (HD) have a higher incidence of fractures than the general population. Sarcopenia is frequently observed in patients on HD; however, the association of falls with sarcopenia and its diagnostic factors, including muscl... (Source: SafetyLit)
Source: SafetyLit - October 2, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Combined ethylene glycol poisoning with methemoglobinemia due to antifreeze ingestion - Kolosionek TJ, Amaducci AM, Fikse DJ, Katz KD.
BACKGROUND: Antifreeze poisoning is potentially life-threatening and often requires multiple antidotal therapies and hemodialysis. Ethylene or propylene glycol toxicity is commonly caused by antifreeze ingestion. However, ingestion of antifreeze is typical... (Source: SafetyLit)
Source: SafetyLit - September 25, 2023 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news
The Mount Sinai Hospital Commemorates 75th Anniversary of First Dialysis Procedure with Continuing Medical Education Event
The Dialysis Odyssey celebrates research advancements changing practice and improving lives of patients today NEW YORK, Sept. 21, 2023 /PRNewswire-PRWeb/ -- Seventy-five years after pioneering doctors at The Mount Sinai Hospital conducted the first hemodialysis treatment in the United... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 21, 2023 Category: Pharmaceuticals Tags: FVT Source Type: news
Fresenius Medical Care Announces FDA Clearance of Versi(R)HD with GuideMe Software
WALTHAM, Mass., Aug. 23, 2023 -- (Healthcare Sales & Marketing Network) -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced the U.S. Food and Drug Administration (FDA) 510(k... Devices, FDA Fresenius Medical Care, Versi®HD, GuideMe Software, hemodialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 23, 2023 Category: Pharmaceuticals Source Type: news
